UnitedHealth Valuation Multiple Soars as Investors Bet on Margin Recovery
UnitedHealth's shares rose by 2.3% to $399.06 on Monday, August 24, 2026, as investors bet on margin recovery despite high commercial medical costs.
The company's valuation is a significant multiple of its earnings, with the stock trading at 20.2 times the midpoint of management's projected adjusted EPS for 2026.
Medical cost growth in the commercial segment remains above 11%, which may hinder complete margin recovery until after 2027.